MedTrace Logo

IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder

NCT01392482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 751725

Last updated 2012-09-17

No results posted yet for this study

Summary

Multicentre, retrospective observational cohort study based on LHU administrative databases aimed to described the pharmacoutilization of antipsychotics in patients affected by schizophrenia and bipolar disorder, the resource consumption and medication adherence. A sub analysis will be performed for those patients switching from Quetiapine IR to Quetiapine XR and comparing the periods before and after the switch.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Flore La Tour · AstraZeneca

  • Raffaele Sabia · AstraZeneca

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01392482 on ClinicalTrials.gov